SV Health Investors, LLC - Q4 2021 holdings

$155 Million is the total value of SV Health Investors, LLC's 6 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 50.0% .

 Value Shares↓ Weighting
BCYC SellBICYCLE THERAPEUTICS PLCsponsored ads$55,888,000
-6.5%
918,154
-36.1%
36.13%
+23.6%
AHCO  ADAPTHEALTH CORP$47,480,000
+5.0%
1,941,1180.0%30.69%
+38.7%
STRO  SUTRO BIOPHARMA INC$27,149,000
-21.2%
1,824,5420.0%17.55%
+4.1%
BVS NewBIOVENTUS, INC$22,909,0001,581,031
+100.0%
14.81%
XFOR  X4 PHARMACEUTICALS INC$713,000
-56.7%
311,4900.0%0.46%
-42.8%
ASXC  ASENSUS SURGICAL, INC.$566,000
-40.0%
510,1420.0%0.37%
-20.8%
RGEN ExitRepligen Corporation$0-14,541
-100.0%
-2.06%
DCPH ExitDECIPHERA PHARMACEUTICALS INC$0-449,951
-100.0%
-7.48%
MSON ExitMISONIX, INC.$0-1,694,017
-100.0%
-20.97%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

  • SVLSF VI, LLC #1
  • SV Life Sciences Fund VI (GP), L.P. #2
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-02-11
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
TRANSENTERIX, INC.27Q4 202024.0%
OCULAR THERAPEUTIX, INC.24Q2 202035.9%
KALVISTA PHARMACEUTICALS INC17Q4 202031.0%
DECIPHERA PHARMACEUTICALS INC17Q3 202131.0%
CATABASIS PHARMACEUTICALS, INC.15Q4 201818.2%
X4 PHARMACEUTICALS INC15Q3 20223.2%
BICYCLE THERAPEUTICS PLC14Q3 202265.4%
SUTRO BIOPHARMA INC14Q4 202119.1%
ENTELLUS MED INC12Q4 201764.4%
AVROBIO INC12Q1 202141.6%

View SV Health Investors, LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR2022-11-07
13F-HR2022-08-12
13F-HR2022-05-16
13F-HR2022-02-11
13F-HR2021-11-15
13F-HR2021-08-16
13F-HR2021-05-17
13F-HR2021-02-16
13F-HR2020-11-12
13F-HR2020-08-14

View SV Health Investors, LLC's complete filings history.

Compare quarters

Export SV Health Investors, LLC's holdings